Phase 1 Randomized Trial of Stereotactic Body Radiation Therapy Followed by Nivolumab plus Ipilimumab or Nivolumab Alone in Advanced/Unresectable Hepatocellular Carcinoma.

Phase 1 Randomized Trial of Stereotactic Body Radiation Therapy Followed by Nivolumab plus Ipilimumab or Nivolumab Alone in Advanced/Unresectable Hepatocellular Carcinoma. Int J Radiat Oncol Biol Phys. 2023 01 01; 115(1):202-213.

View in: PubMed

subject areas

Carcinoma, Hepatocellular
Combined Modality Therapy
Humans
Immunotherapy
Ipilimumab
Liver Neoplasms
Prospective Studies

authors with profiles

Stanley Liauw
Sean Pitroda
Aditya Juloori
Anjana Pillai
Chih-Yi Liao
Rohan Katipally